Linxi Yang

750 total citations · 1 hit paper
15 papers, 529 citations indexed

About

Linxi Yang is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Linxi Yang has authored 15 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Gastroenterology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Linxi Yang's work include Gastrointestinal Tumor Research and Treatment (10 papers), Metastasis and carcinoma case studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Linxi Yang is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (10 papers), Metastasis and carcinoma case studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Linxi Yang collaborates with scholars based in China. Linxi Yang's co-authors include Zizhen Zhang, Ben Yue, Gang Zhao, Ran Cui, Chenlong Song, Bo Ni, Chun Zhuang, Wenyi Zhao, Hui Cao and Lin Tu and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cancer and Cancer Letters.

In The Last Decade

Linxi Yang

14 papers receiving 529 citations

Hit Papers

METTL3-mediated N6-methyladenosine modification is critic... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
    2019 463 citations Ben Yue, Chenlong Song et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linxi Yang China 5 469 292 65 61 46 15 529
Zhenjun Zhao China 7 646 1.4× 481 1.6× 49 0.8× 39 0.6× 33 0.7× 10 692
Junge Deng China 7 345 0.7× 261 0.9× 47 0.7× 13 0.2× 23 0.5× 12 393
Qingya Luo China 9 725 1.5× 427 1.5× 65 1.0× 90 1.5× 33 0.7× 15 779
Xichun Cui China 11 456 1.0× 322 1.1× 58 0.9× 33 0.5× 44 1.0× 14 520
Jin‐Ling Duan China 13 265 0.6× 139 0.5× 105 1.6× 8 0.1× 93 2.0× 29 407
Pooja Yadav India 7 388 0.8× 215 0.7× 50 0.8× 49 0.8× 28 0.6× 16 424
Mingqing Wu China 7 469 1.0× 271 0.9× 76 1.2× 77 1.3× 26 0.6× 15 538
Chunlong Yang China 11 616 1.3× 313 1.1× 80 1.2× 36 0.6× 53 1.2× 16 672
Lisha Zhuang China 7 287 0.6× 181 0.6× 63 1.0× 18 0.3× 23 0.5× 8 336
Lingxing Zeng China 7 292 0.6× 183 0.6× 61 0.9× 17 0.3× 26 0.6× 8 341

Countries citing papers authored by Linxi Yang

Since Specialization
Citations

This map shows the geographic impact of Linxi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxi Yang more than expected).

Fields of papers citing papers by Linxi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linxi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxi Yang. The network helps show where Linxi Yang may publish in the future.

Co-authorship network of co-authors of Linxi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Linxi Yang. A scholar is included among the top collaborators of Linxi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linxi Yang. Linxi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Ming, Linxi Yang, Xudong Qiu, et al.. (2025). Aptamer-based drug delivery for targeted therapy of imatinib-resistant gastrointestinal stromal tumor. Theranostics. 15(17). 8738–8756.
2.
3.
4.
Zhuang, Chun, Xiaoqi Li, Linxi Yang, et al.. (2023). Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors. Frontiers in Oncology. 13. 1151687–1151687. 4 indexed citations
5.
Huang, Chen, Ming Wang, Wenyi Zhao, et al.. (2023). Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1.. PubMed. 15(2). 1026–1040. 1 indexed citations
6.
7.
8.
Zhuang, Chun, Bo Ni, Zizhen Zhang, et al.. (2021). Low Distribution of TIM-3+ Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors. Journal of Immunology Research. 2021. 1–10. 4 indexed citations
9.
10.
11.
Tu, Lin, Linxi Yang, Chun Zhuang, et al.. (2020). [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].. PubMed. 23(9). 872–879. 1 indexed citations
12.
Yue, Ben, Chenlong Song, Linxi Yang, et al.. (2019). METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Molecular Cancer. 18(1). 142–142. 463 indexed citations breakdown →
13.
Yang, Linxi, Ming Wang, Lin Tu, et al.. (2019). [Application of imatinib plasma concentration monitoring in the whole process management of gastrointestinal stromal tumor patients].. PubMed. 22(9). 841–847. 1 indexed citations
14.
Wang, Ming, Bo Ni, Chun Zhuang, et al.. (2019). Aberrant accumulation of Dickkopf 4 promotes tumor progression via forming the immune suppressive microenvironment in gastrointestinal stromal tumor. Cancer Medicine. 8(11). 5352–5366. 11 indexed citations
15.
Gu, Jiayi, Tingyuan Lang, Linxi Yang, et al.. (2019). <p>PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway</p>. OncoTargets and Therapy. Volume 12. 8095–8104. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenjun Zhao Breakdown of academic impact, for papers by Junge Deng Breakdown of academic impact, for papers by Qingya Luo Breakdown of academic impact, for papers by Xichun Cui Breakdown of academic impact, for papers by Jin‐Ling Duan Breakdown of academic impact, for papers by Pooja Yadav Breakdown of academic impact, for papers by Mingqing Wu Breakdown of academic impact, for papers by Chunlong Yang Breakdown of academic impact, for papers by Lisha Zhuang Breakdown of academic impact, for papers by Lingxing Zeng
Rankless by CCL
2026